Critical Risk: Since compounded semaglutide is not FDA-approved, both patients and companies faced: Legal risks (if compounding was deemed improper) Quality risks (purity, dosage variability) Regulatory risks (especially after FDA warnings about compounded GLP-1s) Now, with the Novo Nordisk Partnership: Huge Shift After the recent partnership: Hims & Hers will now offer the real, FDA-approved Wegovy (not compounded versions)
GS: Writing review & editing, Writing original draft, Resources
How GLP-1 Weight Loss Affects Body Shape GLP-1 weight loss medications influence body composition by reducing appetite and improving metabolic regulation
When Bill first spoke with Mens Health in July, he acknowledged the risk he was taking, but he said he was pretty confident that he was doing things safely
How is GHK Cu different from collagen supplements
The FDA has approved these agents for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity